tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FEMY Stock Latest News

Femasys Secures $12 Million Through Private Placement
Company AnnouncementsFemasys Secures $12 Million Through Private Placement
3d ago
8K
FEMY
Femasys Receives FDA Approval for FemBloc Trial
PremiumCompany Announcements
Femasys Receives FDA Approval for FemBloc Trial
7d ago
8K
FEMY
Femasys secures FDA approval to advance final FemBloc trial phase
PremiumThe Fly
Femasys secures FDA approval to advance final FemBloc trial phase
7d ago
FEMY
Femasys, Inc. Advances Non-Surgical Birth Control with FemBloc Study
PremiumCompany Announcements
Femasys, Inc. Advances Non-Surgical Birth Control with FemBloc Study
14d ago
FEMY
Femasys announces initiation of post-market surveillance study for FemBloc
PremiumThe Fly
Femasys announces initiation of post-market surveillance study for FemBloc
19d ago
FEMY
Femasys Meets Nasdaq Equity Requirement After Offering
PremiumCompany AnnouncementsFemasys Meets Nasdaq Equity Requirement After Offering
20d ago
8K
FEMY
Femasys COO Daniel Currie Announces Retirement
Premium
Company Announcements
Femasys COO Daniel Currie Announces Retirement
24d ago
8K
FEMY
Femasys jumps with Trump expected to expand IVF access
Premium
The Fly
Femasys jumps with Trump expected to expand IVF access
25d ago
FEMY
VTI ETF News, 10/3/2025
PremiumMarket News
VTI ETF News, 10/3/2025
1M ago
LVO
VTI
Strategic Partnership with Kebomed Boosts Femasys’ European Expansion for FemBloc
PremiumRatings
Strategic Partnership with Kebomed Boosts Femasys’ European Expansion for FemBloc
2M ago
FEMY
Femasys announces partnership with Kebomend to commercialize FemBloc
PremiumThe Fly
Femasys announces partnership with Kebomend to commercialize FemBloc
2M ago
FEMY
Femasys partners with Medical Electronic Systems for FemSperm kit
PremiumThe Fly
Femasys partners with Medical Electronic Systems for FemSperm kit
2M ago
FEMY
Femasys expands FemSperm product line with Insemination Prep Kit
PremiumThe FlyFemasys expands FemSperm product line with Insemination Prep Kit
2M ago
FEMY
Femasys secures MEDSAFE approval for FemBloc Permanent Birth Control
Premium
The Fly
Femasys secures MEDSAFE approval for FemBloc Permanent Birth Control
2M ago
FEMY
Femasys closes $8M in financing
Premium
The Fly
Femasys closes $8M in financing
2M ago
FEMY
Femasys Announces $8 Million Public Offering
PremiumCompany Announcements
Femasys Announces $8 Million Public Offering
3M ago
8K
FEMY
Femasys announces introduction of FemSperm Setup Kit
PremiumThe Fly
Femasys announces introduction of FemSperm Setup Kit
3M ago
FEMY
Femasys Gains UK Approval for FemBloc Birth Control
PremiumCompany Announcements
Femasys Gains UK Approval for FemBloc Birth Control
3M ago
8K
FEMY
Femasys secures U.K. Regulatory Approval of FemBloc permanent birth control
PremiumThe Fly
Femasys secures U.K. Regulatory Approval of FemBloc permanent birth control
3M ago
FEMY
Femasys files to sell 11.43M shares of common stock
PremiumThe FlyFemasys files to sell 11.43M shares of common stock
3M ago
FEMY
Optimistic Buy Rating for Femasys Driven by Strategic Initiatives and Product Innovations
Premium
Ratings
Optimistic Buy Rating for Femasys Driven by Strategic Initiatives and Product Innovations
3M ago
FEMY
Femasys reports Q2 EPS (16c) vs. (21c) last year
Premium
The Fly
Femasys reports Q2 EPS (16c) vs. (21c) last year
3M ago
FEMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >